“Dr. Amy Abernethy, principal deputy commissioner at the U.S. FDA, discusses the need for regulatory ‘agility’ during the COVID-19 pandemic.” Watch the video here.
Source: FDA’s role in balancing innovation, regulation, safety during pandemic – September 15, 2020. Healthcare IT News.
